Biotheryx to Present Preclinical Data for Its Dual Protein D

Biotheryx to Present Preclinical Data for Its Dual Protein Degrader BTX-1188 at the 2022 American Society of Clinical Oncology Annual Meeting

Biotheryx to Present Preclinical Data for Its Dual Protein Degrader BTX-1188 at the 2022 American Society of Clinical Oncology Annual Meeting

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Illinois , United States , Chicago , American , Ikaros Aiolos , Aparajita Hoskote Chourasia , Philippe Drouet , Leah Fung , Linkedin , American Society Of Clinical Oncology , Biotheryx Inc , Drug Administration , Prnewswire Biotheryx Inc , Development For The Treatment Of Hematologic , Beneficial Immunomodulatory Properties , Durable Dual Degradation , Vitro Along , Beneficial Immunomodulatory , Support Ongoing Phase , Solid Tumor , Clinical Oncology , Annual Meeting , Chief Scientific Officer , Chief Executive Officer , Abstract Number , Hematologic Malignancies , Myelodysplastic Syndromes ,